Immunovant
IMVT
IMVT
147 hedge funds and large institutions have $1.86B invested in Immunovant in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
+32
Holders Change %
+27.83%
% of All Funds
2.61%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
44
Increased
54
Reduced
39
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$222M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$52.1M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$86.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$179M |
| 5 |
5
Goldman Sachs
New York
|
$36.3M |
